176 related articles for article (PubMed ID: 33849662)
1. Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells.
Álvarez-Palomo B; García-Martinez I; Gayoso J; Raya A; Veiga A; Abad ML; Eiras A; Guzmán-Fulgencio M; Luis-Hidalgo M; Eguizabal C; Santos S; Balas A; Alenda R; Sanchez-Gordo F; Verdugo LP; Villa J; Carreras E; Vidal F; Madrigal A; Herrero MJ; Rudilla F; Querol S
Stem Cell Res Ther; 2021 Apr; 12(1):233. PubMed ID: 33849662
[TBL] [Abstract][Full Text] [Related]
2. Generation of a bank of clinical-grade, HLA-homozygous iPSC lines with high coverage of the Spanish population.
Kuebler B; Alvarez-Palomo B; Aran B; Castaño J; Rodriguez L; Raya A; Querol Giner S; Veiga A
Stem Cell Res Ther; 2023 Dec; 14(1):366. PubMed ID: 38093328
[TBL] [Abstract][Full Text] [Related]
3. Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple Populations.
Lee S; Huh JY; Turner DM; Lee S; Robinson J; Stein JE; Shim SH; Hong CP; Kang MS; Nakagawa M; Kaneko S; Nakanishi M; Rao MS; Kurtz A; Stacey GN; Marsh SGE; Turner ML; Song J
Stem Cells; 2018 Oct; 36(10):1552-1566. PubMed ID: 30004605
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of the Hematopoietic Stem Cell Donor Pool as a Source of HLA-Homozygous Induced Pluripotent Stem Cells for Haplobanking: Combined Analysis of the Cord Blood Inventory and Bone Marrow Donor Registry.
Shin S; Song EY; Kwon YW; Oh S; Park H; Kim NH; Roh EY
Biol Blood Marrow Transplant; 2020 Aug; 26(8):e202-e208. PubMed ID: 32439474
[TBL] [Abstract][Full Text] [Related]
5. Proceedings: human leukocyte antigen haplo-homozygous induced pluripotent stem cell haplobank modeled after the california population: evaluating matching in a multiethnic and admixed population.
Pappas DJ; Gourraud PA; Le Gall C; Laurent J; Trounson A; DeWitt N; Talib S
Stem Cells Transl Med; 2015 May; 4(5):413-8. PubMed ID: 25926330
[TBL] [Abstract][Full Text] [Related]
6. The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines.
Gourraud PA; Gilson L; Girard M; Peschanski M
Stem Cells; 2012 Feb; 30(2):180-6. PubMed ID: 22045598
[TBL] [Abstract][Full Text] [Related]
7. Umbilical Cord Blood Units Cryopreserved in the Public Cord Blood Bank: A Breakthrough in iPSC Haplobanking?
Roh EY; Oh S; Yoon JH; Kim BJ; Song EY; Shin S
Cell Transplant; 2020; 29():963689720926151. PubMed ID: 32623908
[TBL] [Abstract][Full Text] [Related]
8. Creating an HLA-homozygous iPS cell bank for the Brazilian population: Challenges and opportunities.
Martins de Oliveira ML; Tura BR; Meira Leite M; Melo Dos Santos EJ; Pôrto LC; Pereira LV; Campos de Carvalho AC
Stem Cell Reports; 2023 Oct; 18(10):1905-1912. PubMed ID: 37774702
[TBL] [Abstract][Full Text] [Related]
9. Haplobanking induced pluripotent stem cells for clinical use.
Sullivan S; Fairchild PJ; Marsh SGE; Müller CR; Turner ML; Song J; Turner D
Stem Cell Res; 2020 Dec; 49():102035. PubMed ID: 33221677
[TBL] [Abstract][Full Text] [Related]
10. Risk of HLA Homozygous Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation.
Morishima Y; Azuma F; Kashiwase K; Matsumoto K; Orihara T; Yabe H; Kato S; Kato K; Kai S; Mori T; Nakajima K; Morishima S; Satake M; Takanashi M; Yabe T;
Stem Cells Transl Med; 2018 Feb; 7(2):173-179. PubMed ID: 29274116
[TBL] [Abstract][Full Text] [Related]
11. A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population.
Yoshida S; Kato TM; Sato Y; Umekage M; Ichisaka T; Tsukahara M; Takasu N; Yamanaka S
Med; 2023 Jan; 4(1):51-66.e10. PubMed ID: 36395757
[TBL] [Abstract][Full Text] [Related]
12. Impact of Homozygous Conserved Extended HLA Haplotype on Single Cord Blood Transplantation: Lessons for Induced Pluripotent Stem Cell Banking and Transplantation in Allogeneic Settings.
Morishima Y; Morishima S; Murata M; Arima N; Uchida N; Sugio Y; Takahashi S; Matsuhashi Y; Onizuka M; Eto T; Nagafuji K; Onishi Y; Inoue M; Atsuta Y; Fukuda T; Ichinohe T; Kato S; Kanda J
Biol Blood Marrow Transplant; 2020 Jan; 26(1):132-138. PubMed ID: 31521817
[TBL] [Abstract][Full Text] [Related]
13. Public Cord Blood Banks as a source of starting material for clinical grade HLA-homozygous induced pluripotent stem cells.
Álvarez-Palomo B; Veiga A; Raya A; Codinach M; Torrents S; Ponce Verdugo L; Rodriguez-Aierbe C; Cuellar L; Alenda R; Arbona C; Hernández-Maraver D; Fusté C; Querol S
Stem Cell Res Ther; 2022 Aug; 13(1):408. PubMed ID: 35962457
[TBL] [Abstract][Full Text] [Related]
14. HLA-based banking of induced pluripotent stem cells in Saudi Arabia.
Alowaysi M; Lehmann R; Al-Shehri M; Baadhaim M; Alzahrani H; Aboalola D; Zia A; Malibari D; Daghestani M; Alghamdi K; Haneef A; Jawdat D; Hakami F; Gomez-Cabrero D; Tegner J; Alsayegh K
Stem Cell Res Ther; 2023 Dec; 14(1):374. PubMed ID: 38111036
[TBL] [Abstract][Full Text] [Related]
15. Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cells.
Meyer-Monard S; Passweg J; Troeger C; Eberhard HP; Roosnek E; de Faveri GN; Chalandon Y; Rovo A; Kindler V; Irion O; Holzgreve W; Gratwohl A; Müller C; Tichelli A; Tiercy JM
Bone Marrow Transplant; 2009 May; 43(10):771-8. PubMed ID: 19060930
[TBL] [Abstract][Full Text] [Related]
16. Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical Applications.
Abberton KM; McDonald TL; Diviney M; Holdsworth R; Leslie S; Delatycki MB; Liu L; Klamer G; Johnson P; Elwood NJ
Stem Cells Transl Med; 2022 Oct; 11(10):1052-1060. PubMed ID: 36073721
[TBL] [Abstract][Full Text] [Related]
17. Recent progress of national banking project on homozygous HLA-typed induced pluripotent stem cells in South Korea.
Rim YA; Park N; Nam Y; Ham DS; Kim JW; Ha HY; Jung JW; Jung SM; Baek IC; Kim SY; Kim TG; Song J; Lee J; Park SH; Chung NG; Yoon KH; Ju JH
J Tissue Eng Regen Med; 2018 Mar; 12(3):e1531-e1536. PubMed ID: 28941241
[TBL] [Abstract][Full Text] [Related]
18. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors.
Sugita S; Iwasaki Y; Makabe K; Kimura T; Futagami T; Suegami S; Takahashi M
Stem Cell Reports; 2016 Oct; 7(4):619-634. PubMed ID: 27641646
[TBL] [Abstract][Full Text] [Related]
19. HLA-A, HLA-B, HLA-DRB1 allele and haplotype frequencies in 6384 umbilical cord blood units and transplantation matching and engraftment statistics in the Zhejiang cord blood bank of China.
Wang F; He J; Chen S; Qin F; Dai B; Zhang W; Zhu FM; Lv HJ
Int J Immunogenet; 2014 Feb; 41(1):13-9. PubMed ID: 23731569
[TBL] [Abstract][Full Text] [Related]
20. [Present and Future of an iPS Cell Stock for Regenerative Medicine].
Hanatani T; Takasu N
Rinsho Byori; 2017 Feb; 65(2):160-166. PubMed ID: 30762982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
